Previous Close | 14.42 |
Open | 14.50 |
Bid | 14.66 x 200 |
Ask | 14.70 x 100 |
Day's Range | 14.45 - 14.68 |
52 Week Range | 13.21 - 15.44 |
Volume | |
Avg. Volume | 425,545 |
Market Cap | 756.154M |
Beta (5Y Monthly) | 0.63 |
PE Ratio (TTM) | 9.23 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.04 (14.14%) |
Ex-Dividend Date | Jun 28, 2024 |
1y Target Est | N/A |
Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity" or the "Company"), a leading provider of financing solutions to growth-stage companies, today announced that it has launched a new vehicle in partnership with Eagle Point Credit Management LLC ("Eagle Point Credit"). Trinity's wholly owned registered investment adviser will be an adviser to the new vehicle, thereby bolstering the Company's sources of capital for lending and generating non-capital intensive fee income.
Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced the appointment of Josh Ruben as Managing Director of Life Sciences. Mr. Ruben, an established leader with over a decade of experience in investment banking, has a long track record of supporting life science companies with over $50 billion of transactions completed across M&A and capital raises. He is based in Phoenix, AZ.
Trinity Capital Inc. (Nasdaq: TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-stage companies, today announced that it will release its second quarter 2024 financial results before market open on Wednesday, August 7, 2024. The Company will discuss its financial results on a conference call that day at 9:00 a.m. PT (12:00 p.m. ET).